In our study, CBX6 and CBX7 were favorable prognostic factors for ccRCC, and low CBX6 and CBX7 expression was positively associated with advanced cancer stage and tumor grade in ccRCC patients. This evidence concerns the gene CBX6 and nonpapillary renal cell carcinoma.